219 related articles for article (PubMed ID: 32817421)
1. Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer.
Itatani Y; Yamamoto T; Zhong C; Molinolo AA; Ruppel J; Hegde P; Taketo MM; Ferrara N
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21598-21608. PubMed ID: 32817421
[TBL] [Abstract][Full Text] [Related]
2. Bv8 regulates myeloid-cell-dependent tumour angiogenesis.
Shojaei F; Wu X; Zhong C; Yu L; Liang XH; Yao J; Blanchard D; Bais C; Peale FV; van Bruggen N; Ho C; Ross J; Tan M; Carano RA; Meng YG; Ferrara N
Nature; 2007 Dec; 450(7171):825-31. PubMed ID: 18064003
[TBL] [Abstract][Full Text] [Related]
3. G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models.
Shojaei F; Wu X; Qu X; Kowanetz M; Yu L; Tan M; Meng YG; Ferrara N
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6742-7. PubMed ID: 19346489
[TBL] [Abstract][Full Text] [Related]
4. Bv8 mediates myeloid cell migration and enhances malignancy of colorectal cancer.
Li X; Chang E; Cui J; Zhao H; Hu C; O'Dea KP; Tirlapur N; Balboni G; Zhang J; Ying L; Ma D
Front Immunol; 2023; 14():1158045. PubMed ID: 37090721
[TBL] [Abstract][Full Text] [Related]
5. Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1.
Lu R; Kujawski M; Pan H; Shively JE
Cancer Res; 2012 May; 72(9):2239-50. PubMed ID: 22406619
[TBL] [Abstract][Full Text] [Related]
6. [Mouse models for human colorectal cancer with liver metastasis].
Huang XD; Zheng YB; Yang YJ; Yang C; Li HL; Cheng HR
Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(34):2701-2705. PubMed ID: 31505723
[No Abstract] [Full Text] [Related]
7. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
8. Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer.
Schiffmann LM; Fritsch M; Gebauer F; Günther SD; Stair NR; Seeger JM; Thangarajah F; Dieplinger G; Bludau M; Alakus H; Göbel H; Quaas A; Zander T; Hilberg F; Bruns CJ; Kashkar H; Coutelle O
Br J Cancer; 2019 Jan; 120(1):69-78. PubMed ID: 30377339
[TBL] [Abstract][Full Text] [Related]
9. An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy.
Chung AS; Wu X; Zhuang G; Ngu H; Kasman I; Zhang J; Vernes JM; Jiang Z; Meng YG; Peale FV; Ouyang W; Ferrara N
Nat Med; 2013 Sep; 19(9):1114-23. PubMed ID: 23913124
[TBL] [Abstract][Full Text] [Related]
10. Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cells.
Shojaei F; Ferrara N
Cancer Res; 2008 Jul; 68(14):5501-4. PubMed ID: 18632597
[TBL] [Abstract][Full Text] [Related]
11. Combined Mutation of
Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
[TBL] [Abstract][Full Text] [Related]
12. The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent Angiogenesis.
Negri L; Ferrara N
Physiol Rev; 2018 Apr; 98(2):1055-1082. PubMed ID: 29537336
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy-specific glycoprotein 9 (PSG9), a driver for colorectal cancer, enhances angiogenesis via activation of SMAD4.
Yang L; Hu S; Tan J; Zhang X; Yuan W; Wang Q; Xu L; Liu J; Liu Z; Jia Y; Huang X
Oncotarget; 2016 Sep; 7(38):61562-61574. PubMed ID: 27528036
[TBL] [Abstract][Full Text] [Related]
14. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
[TBL] [Abstract][Full Text] [Related]
15. Stromal iodothyronine deiodinase 2 (DIO2) promotes the growth of intestinal tumors in Apc
Kojima Y; Kondo Y; Fujishita T; Mishiro-Sato E; Kajino-Sakamoto R; Taketo MM; Aoki M
Cancer Sci; 2019 Aug; 110(8):2520-2528. PubMed ID: 31215118
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils.
Ohki Y; Heissig B; Sato Y; Akiyama H; Zhu Z; Hicklin DJ; Shimada K; Ogawa H; Daida H; Hattori K; Ohsaka A
FASEB J; 2005 Dec; 19(14):2005-7. PubMed ID: 16223785
[TBL] [Abstract][Full Text] [Related]
17. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps.
Seno H; Oshima M; Ishikawa TO; Oshima H; Takaku K; Chiba T; Narumiya S; Taketo MM
Cancer Res; 2002 Jan; 62(2):506-11. PubMed ID: 11809702
[TBL] [Abstract][Full Text] [Related]
19. Characterization and regulation of bv8 in human blood cells.
Zhong C; Qu X; Tan M; Meng YG; Ferrara N
Clin Cancer Res; 2009 Apr; 15(8):2675-84. PubMed ID: 19336519
[TBL] [Abstract][Full Text] [Related]
20. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression.
Shojaei F; Singh M; Thompson JD; Ferrara N
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2640-5. PubMed ID: 18268320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
